reo 033
reo 033: developed by 1 company · 1 FDA decision. Updated within the last hour.
Lead developer: ONCOLYTICS BIOTECH INC (ONCY)
Development Pipeline (1)
| Company | Phase |
|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | — |
FDA Decisions
Frequently asked questions
Who is developing reo 033?
reo 033 is being developed by ONCOLYTICS BIOTECH INC.
What is reo 033's latest FDA decision?
The most recent tracked FDA decision for reo 033 is FDA_Meeting for Discuss plans for registrational expansion and other study design elements..
Analyze ONCOLYTICS BIOTECH INC & reo 033 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company